CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis

Na Young Lee, Min Jea Shin, Gi Soo Youn, Sang Jun Yoon, Ye Rin Choi, Hyeong Seop Kim, Haripriya Gupta, Sang Hak Han, Byoung Kook Kim, Do Yup Lee, Tae Sik Park, Hotaik Sung, Byung Yong Kim, Ki Tae Suk

Clin Mol Hepatol. 2021;27(1):110-124. Published online 2020 December 3 DOI: https://doi.org/10.3350/cmh.2020.0125

<i>Lactobacillus</i> attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis

Na Young Lee, Min Jea Shin, Gi Soo Youn, Sang Jun Yoon, Ye Rin Choi, Hyeong Seop Kim, Haripriya Gupta, Sang Hak Han, Byoung Kook Kim, Do Yup Lee, Tae Sik Park, Hotaik Sung, Byung Yong Kim, Ki Tae Suk

Clinical and Molecular Hepatology. 2021;27(1):110-124

Link1

Link2 Link3

Noninvasive Evaluation of Fibrosis and Steatosis in Nonalcoholic Fatty Liver Disease by Elastographic Methods

Monica Lupsor-Platon

Non-Alcoholic Fatty Liver Disease - Molecular Bases, Prevention and Treatment. 2018;

Link1

Sulforaphane Attenuates Nonalcoholic Fatty Liver Disease by Inhibiting Hepatic Steatosis and Apoptosis

Jinwang Li, Siyu Xie, Wendi Teng

Nutrients. 2021;14(1):76

Link1

Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease

Pierre Bedossa,

Hepatology. 2014;60(2):565-575

Link1 Link2

Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”

Yuanbin Liu, Mingkai Chen

Clinical and Molecular Hepatology. 2023;29(1):163-164

Link1

Link2 Link3

Do Zones of Hepatic Steatosis Associate With Subtypes and Progression of Nonalcoholic Fatty Liver Disease in Children?

Veeral Ajmera, Rohit Loomba

Clinical Gastroenterology and Hepatology. 2018;16(3):341-342

Link1 Link2

Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis

Geoffrey C. Farrell, Claire Z. Larter

Hepatology. 2006;43(Supplement 1):S99-S112

Link1 Link2

Interleukin-17 Integrates Hepatic Steatosis and Inflammation in Nonalcoholic Fatty Liver Disease

Xiong Ma

Gastroenterology. 2011;140(5):S-702

Link1 Link2

Does Nonalcoholic Pancreatic Steatosis Always Correlate with Nonalcoholic Fatty Liver Disease?

Celal Ulasoglu, Zeynep Nilufer Tekin, Kubra Akan, Arda Yavuz

Clinical and Experimental Gastroenterology. 2021;Volume 14:269-275

Link1 Link2

Management of nonalcoholic fatty liver disease in children

Jean P. Molleston

Clinical Liver Disease. 2012;1(4):129-130

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.